Skip to main content

Gilead Sciences, Inc. v. Natco Pharma Limited

Certiorari Denied

Petition for certiorari denied on March 9, 2015.

Docket No.14-647
Op. BelowFed. Cir.
SCOTUS Page

Issue

Whether, contrary to this Court"s consistent and longstanding precedent and Congress"s intent, the double-patenting doctrine can be used to invalidate a properly issued patent before its statutory term has expired using a second, later-issuing patent whose term of exclusivity is entirely subsumed within that first patent"s term.

Proceedings & orders timeline

Oct 9, 2014
Application (14A391) to extend the time to file a petition for a writ of certiorari from October 27, 2014 to November 26, 2014, submitted to The Chief Justice.
Oct 15, 2014
Application (14A391) granted by The Chief Justice extending the time to file until November 26, 2014.
Nov 26, 2014
Petition for a writ of certiorari filed. (Response due January 5, 2015)
Dec 22, 2014
Order extending time to file response to petition to and including February 4, 2015.
Dec 29, 2014
Brief amici curiae of The Pharmaceutical Research and Manufacturers of America, et al, filed.
Feb 4, 2015
Brief of respondents Natco Pharma Limited, et al. in opposition filed.
Feb 17, 2015
Reply of petitioners Gilead Sciences, Inc., et al. filed.
Feb 18, 2015
DISTRIBUTED for Conference of March 6, 2015.
Mar 9, 2015
Petition DENIED.

Welcome to SCOTUSblog

Tell us a bit about yourself so we can tailor what you see. You can update these any time in your account.